Whitepaper: Recombinant factor C: new Ph. Eur. Chapter 2.6.32
Posted: 14 December 2020 | bioMérieux | No comments yet
Test for bacterial endotoxins using recombinant factor C for their bacterial endotoxin testing (BET) without needing to validate the method. On 1 January 2021, the new general chapter 2.6.32. and
revised general chapter 5.1.10. Guidelines for using the test for bacterial endotoxins, will come into effect.
Related content from this organisation
- European Pharmaceutical Review Issue 4 2024
- Application note: Automated nucleic acid amplification assay for mycoplasma detection in cell and gene therapy products
- Next-Generation Rapid mRNA Vaccine CQA Analytics
- Application note: Role of in-house isolates in pharmaceutical quality control
- Application note: Low Endotoxin Recovery case study